Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Roivant Sciences Ltd.

Roivant Sciences Ltd. (ROIVW) Stock Overview

Explore Roivant Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

ROIVW●NASDAQ
HealthcareBiotechnology
$2.75
$0.12(4.56%)
U.S. Market opens in 15h 20m

Roivant Sciences Ltd. (ROIVW)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-77.50
EPS (TTM)$-4.09
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$6.26

ROIVW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Roivant Sciences Ltd. (NASDAQ: ROIVW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Roivant Sciences Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ROIVW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $6.26 for the NASDAQ listing.

Key metrics behind Roivant Sciences Ltd.'s NASDAQ-traded stock include a P/E ratio of -77.50 and a market capitalization of 2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ROIVW on the NASDAQ.

Price Performance (NASDAQ: ROIVW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
105.22%
5-Year Change
75.16%
All-Time (Max) Change
75.16%

Contact Information

http://roivant.com
44 4412 955 950
11-12 St. James’s Square, London, NaN, SW1Y 4LB

Company Facts

6,200 Employees
IPO DateSep 27, 2021
CountryGB

Frequently Asked Questions